Norwegian Scientific Committee for Food and Environment

AB Science reports a first complete bone marrow response in a relapsed refractory acute myeloid leukemia patient from the very low dose arm of its AB8939 Phase I/II clinical trial (AB18001)

Retrieved on: 
Monday, March 13, 2023
Disease, MECOM, HIV disease progression rates, Norwegian Scientific Committee for Food and Environment, Efficacy, AML, Acute leukemia, Maintenance, LIVE, CET, Azacitidine, Toxicity, Science, Acute myeloid leukemia, Euronext, Failure, Bone marrow, Patient, Toxic leukoencephalopathy, MDS, Mortality, MDA, DSM-IV codes, Broadcasting, Pharmaceutical industry, Vaccine, MD, Pharmacokinetics, Safety

Remarkably, this response was achieved at a very low dose of AB8939, corresponding to the second step of dose increment (out of 13 potential steps) in phase I.

Key Points: 
  • Remarkably, this response was achieved at a very low dose of AB8939, corresponding to the second step of dose increment (out of 13 potential steps) in phase I.
  • At the request of the investigator, AB Science has authorized further treatment cycles of AB8939 to this patient.
  • AB8939 treatment of this AML subpopulation is the subject matter of a provisional patent application filed by AB Science.
  • Study AB18001 is titled ‘A Phase 1/2 Study to Assess the Safety, Pharmacokinetics, and Efficacy of Daily Intravenous AB8939 in patients with Relapsed/Refractory Acute Myeloid Leukemia’.

China's Pet Food Industry Gathers at CAFIC Suzhou to Discuss Latest Industry Trends and Technologies

Retrieved on: 
Monday, October 10, 2022
Well, Conference, APC, Texas A&M University, Norwegian Scientific Committee for Food and Environment, Satellite dish, Micronutrient, USDA, Communication, Technology, Italian Trade Agency, PETS, Technical, Marketing, Industry, Skin, Investment Commission, JRS, Kansas State University, Animal, Oil, Intelligence, Multimedia, Chinese Academy of Agricultural Sciences, Wisconsin Department of Agriculture, Trade and Consumer Protection, Compliance, Bachelor of Engineering, NARA, Cognition, Health, Founder, Sorghum, Fats, Feed manufacturing, Bottled water, Electricity

With China's pet economy continuing to boom which expected to be worth over 240 billion yuan by 2025, the conference gathered professionals from across the country to discuss latest trends and technologies in the pet food industry.

Key Points: 
  • With China's pet economy continuing to boom which expected to be worth over 240 billion yuan by 2025, the conference gathered professionals from across the country to discuss latest trends and technologies in the pet food industry.
  • Dr. Yulong Yin,China's world renowned animal nutritionist, presented the "2022 Hexa-I Award of Chinese Pet Food Industry" to Fuzheng Wang (chairman of Liaoning Oceanking Organic Pet Food), Yingchun Wang (chairman of Full Pet), Yiwu Wang (chairman of Metz Pet Food), Qing Li (chairman of Tai'an Taichong Pet Food), Rongkun Wang (chairman of Ronsy Pet Food), Bin Lv (chairman of Shandong Dehai Biotechnology), Shengbo Ye (co-founder of Alfie & Buddy), Yueyue Wang (commercial director of Mars Pet Food China), Jinfa Chen (Technical director of Gambol Pet Food), Zhongming You (Vice President of Petpal Pet Nutrition Technology), Jianshe Sun (general manager of FISH4PETS Pet Food),and Han Peng (Founder of Gaoyejia Pet Food), for their outstanding work.
  • The Scientific Committee also presented the "2022 Triple I Award for Pet Food Ingredient Industry" to pet food ingredient suppliers who achieved excellence in the supply of pet food ingredients and development of pet food technologies.
  • In total, over 400 professionals from various aspects of the Chinese pet food industry including ingredient suppliers and equipment suppliers, attended CAFIC 2022 and CAFEC 2022.

AB Science announces that Health Canada has granted authorization to file a New Drug Submission for masitinib in the treatment of ALS under the Notice of Compliance with Conditions (NOC/c) policy

Retrieved on: 
Monday, February 21, 2022
Risk, Cell, Calendar, File, Compliance, AB, Population, Degenerative disease, Veterinary medicine, AMF, Tyrosine kinase inhibitor, Diagnosis, Company, Medicine, Euronext Paris, Safety, Disease, Amyotrophic lateral sclerosis, Norwegian Scientific Committee for Food and Environment, Condition, Review, Riluzole, Inflammation, Edaravone, ALS, Pengkhianatan G30S/PKI, News, Neurodegeneration, Lists of diseases, Health Canada, Patient, Marketing, Survival, NOC, Euronext, CEO, Research, CET, Science, Mortality, Policy, Pharmaceutical industry, Medical device, Vaccine

AB Science SA (Euronext - FR0010557264 - AB) today announces that Health Canada has granted authorization to file a New Drug Submission for masitinib in the treatment of amyotrophic lateral sclerosis (ALS) under the Notice of Compliance with Conditions (NOC/c) policy.

Key Points: 
  • AB Science SA (Euronext - FR0010557264 - AB) today announces that Health Canada has granted authorization to file a New Drug Submission for masitinib in the treatment of amyotrophic lateral sclerosis (ALS) under the Notice of Compliance with Conditions (NOC/c) policy.
  • Market authorization under the NOC/c policy allows Health Canada to provide earlier market access to potentially life-saving drugs.
  • An assessment named Advance Consideration, performed by a Health Canada Adjudicating Committee, is necessary before being granted authorization to file under NOC/c policy.
  • The Adjudicating Committee has concluded that the request does fulfill the criteria for filing and advance consideration under the NOC/c policy.

5StarWines & Wine Without Walls returns to Vinitaly 2022 with the expertise of a renewed General Chairs panel

Retrieved on: 
Wednesday, January 19, 2022
Taste, Face, Guide, Norwegian Scientific Committee for Food and Environment, Le Figaro, Chair, Die Welt, VIA, General officer, Collection, Panel, Female, Master of Wine, Veteran, Woman, Selection, Forbes, Education, Food, Work, Early Bird, Male, Life, Judgement, Book, Wine, Wine

VERONA, Italy, Jan. 19, 2022 /PRNewswire-PRWeb/ --This year marks the sixth renewal of 5StarWines & Wine Without Walls, which will celebrate the return to Vinitaly 2022, as per tradition.

Key Points: 
  • VERONA, Italy, Jan. 19, 2022 /PRNewswire-PRWeb/ --This year marks the sixth renewal of 5StarWines & Wine Without Walls, which will celebrate the return to Vinitaly 2022, as per tradition.
  • The General Chairs panel of 2022, the most important in the Selection, will be represented by six renowned judges.
  • In the sixth edition of 5StarWines & Wine Without Walls, the Scientific Committee and the jury will be back to tasting in the days preceding Vinitaly 2022.
  • Vinitaly, one of the most important fair trades in the wine industry, works together with 5StarWines & Wine Without Walls towards the promotion of Italian wine, on the international market.